Data from Alipay and other Alipay+ partner payment apps indicates a notable increase in both outbound and inbound tourism spending in China during the 2025 Labor Day holiday (Golden Week). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250505144383/en/The Myeongdong shopping area in South Korea welcomes travelers to pay with Alipay and other Alipay+ partner payment apps. Outbound Travel: Chinese tourists explore local experiences thr...

Veracode, a global leader in application risk management, today announced new capabilities to help organizations address emerging threats, giving security professionals better visibility and control in one place. The launch includes new AI-powered functionality in the Dynamic Application Security Testing (DAST) product and an External Attack Surface Management (EASM) capability. Together, they enable security teams to discover their entire attack surface and prioritize the most critical risk to...

Using zinc to build a single home prevents more than 50 tonnes in carbon emissions, and if just ten percent of new homes in North America were built using zinc, more than 40 million tonnes in carbon emissions would be prevented. These impressive numbers demonstrating zinc’s success story as an agent of decarbonization are the first results of the International Zinc Association’s new Zinc Enables Decarbonization (ZED) initiative, a partnership between the International Zinc Association and Envir...

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNA interference (RNAi) therapeutics company, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of its RNAi therapeutic vutrisiran for the treatment of wild type or hereditary transthyretin amyloidosis in adult patients with cardiomyopathy (ATTR-CM). ATTR-CM is a debilitating, rapidly progressive and potentially fatal ...

HistoSonics, the developer of the Edison Histotripsy System, announced today 12-month follow-up clinical data from its prospective #HOPE4LIVER trials, designed to evaluate the safety and efficacy of histotripsy for the non-invasive destruction of primary (hepatocellular cancer-HCC) and metastatic liver tumors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250428931117/en/ The Edison System, which received U.S. Food and Drug Administ...

Jacek Olczak, Chief Executive Officer of Philip Morris International Inc. (NYSE: PM), outlined the need for common-sense regulations in the consumer goods sector while addressing global leaders at Semafor’s annual World Economy Summit in Washington, D.C., on April 25, 2025. Olczak emphasized the sector’s potential for innovation-led growth despite the volatile economic environment. He stressed, however, that without appropriate regulation and policy frameworks to enable scientific evaluation an...

Headline of release issued April 22, 2025, at 9:30 p.m. PT/April 23, 2025, at 12:30 a.m. ET should read: Saviynt Hires Identity Veteran Roger Hsu to Accelerate Asia Growth (instead of Saviynt Hires Former SailPoint ASEAN Leader Roger Hsu to Accelerate Asia Growth). The updated release reads: SAVIYNT HIRES IDENTITY VETERAN ROGER HSU TO ACCELERATE ASIA GROWTH Appointment of cybersecurity veteran underscores Saviynt’s commitment to identity security amid rising threats and rapid growth across A...

Mainstay Medical Holdings plc today announced that Anthem Blue Cross and Blue Shield (“Anthem”) has established favorable coverage for the company’s ReActiv8 Restorative NeurostimulationTM therapy for the treatment of intractable chronic low back pain. ReActiv8 is the only therapy considered medically necessary by the policy when the conditions for coverage are met. The coverage went into effect on April 16, 2025, and expands access to the procedure, when clinically appropriate, to Anthem’s pol...